The estimated Net Worth of Michael Enxing is at least $3.7 million dollars as of 4 April 2017. Michael Enxing owns over 1,500 units of Nevro Corp stock worth over $197,646 and over the last 10 years Michael sold NVRO stock worth over $3,503,885.
Michael has made over 20 trades of the Nevro Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently Michael exercised 1,500 units of NVRO stock worth $5,400 on 4 April 2017.
The largest trade Michael's ever made was selling 38,500 units of Nevro Corp stock on 6 March 2017 worth over $3,503,885. On average, Michael trades about 6,316 units every 17 days since 2014. As of 4 April 2017 Michael still owns at least 41,963 units of Nevro Corp stock.
You can see the complete history of Michael Enxing stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 1800 Bridge Pkwy, Redwood City, CA 94065, USA.
Over the last 10 years, insiders at Nevro Corp have traded over $298,472,982 worth of Nevro Corp stock and bought 312,708 units worth $8,709,518 . The most active insiders traders include Ali Behbahani, Holdings A/S Novo et & Johnson Johnson & Johnson.... On average, Nevro Corp executives and independent directors trade stock every 18 days with the average trade being worth of $161,002. The most recent stock trade was executed by Shawn Mc Cormick on 7 June 2023, trading 7,500 units of NVRO stock currently worth $171,600.
headquartered in redwood city, california, nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. nevro has developed and commercialized the senza spinal cord stimulation (scs) system, an evidence-based neuromodulation platform for the treatment of chronic pain. the senza system is the only scs system that delivers nevro's proprietary hf10 therapy. the nevro® senza® scs system received ce mark in 2010, tga approval in 2011, fda approval in 2015, and is commercially available in europe, australia, and the united states.
Nevro Corp executives and other stock owners filed with the SEC include: